Cellebrite DI Ltd. (CLBT) Total liabilities 2020–2025
Cellebrite DI Ltd. (CLBT) total liabilities at each fiscal year-end, per SEC filings.
$454.5MFY2025 · since FY2020: $199.4M → $454.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $454.5M | +28.2% |
| FY2024 | $354.5M | -28.9% |
| FY2023 | $498.7M | +51.4% |
| FY2022 | $329.4M | -20.3% |
| FY2021 | $413.1M | +107.2% |
| FY2020 | $199.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLBT financial trends
CLBT RevenueCLBT Net incomeCLBT Net marginCLBT Gross profitCLBT Gross marginCLBT Operating incomeCLBT Operating marginCLBT Operating cash flowCLBT Free cash flowCLBT Capital expendituresCLBT Return on equityCLBT Stock buybacksCLBT Dividends paidCLBT Total assetsCLBT Shareholders’ equityCLBT overview →